Super High-Pressure NC PTCA Balloon (OPN NC)
DeviceStrategy of Super High-Pressure NC PTCA Balloon (OPN NC) after unsuccessful lesion preparation with conventional NC balloon angioplasty.
NCT Number: NCT03487432
The objective of this prospective, multicenter, randomized, open-label trial is to evaluate the completeness of stent expansion following a strategy of lesion preparation with either a Super High-Pressure NC PTCA Balloon (OPN NC) or a Scoring PTCA Balloon (NSE Alpha) after unsuccessful lesion preparation with conventional NC balloon angioplasty in an angiographically well-defined group of patients with severely calcified coronary lesions (grade 3) undergoing coronary stent implantation (SYNERGY everolimus-eluting stent (EES)).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Universitäts-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Strategy of Super High-Pressure NC PTCA Balloon (OPN NC) after unsuccessful lesion preparation with conventional NC balloon angioplasty.
Strategy of Scoring PTCA Balloon (NSE Alpha) after unsuccessful lesion preparation with conventional NC balloon angioplasty.
Time frame: intraprocedural
Stent expansion index (SEI), defined as minimum stent area divided by mean reference area in an optical coherence tomography (OCT) quantitative analysis
Time frame: intraprocedural
'Angiographic Success', defined as the achievement of residual angiographic stenosis <30% of the target lesion in the presence of TIMI 3 flow
Time frame: 30 days
'Procedural Success', defined as the achievement of angiographic success without any MACE, defined as cardiac death, target vessel related myocardial infarction and repeat revascularization (PTCA/PCI or coronary artery bypass graft [CABG])
Time frame: intraprocedural
'Strategy Success' defined as procedural success using the assigned study device and stent, without requirement for lesion preparations with further devices (i.e. rotational atherectomy [RA])
Time frame: intraprocedural
Acute lumen gain, defined as minimal lumen diameter (MLD) post balloon angioplasty minus baseline MLD (mm)
Time frame: intraprocedural
Number of complementary lesion preparations with further devices (i.e. rotational atherectomy [RA])
Time frame: intraprocedural
Rate of vessel perforation
Time frame: intraprocedural
Procedure duration in min
Time frame: intraprocedural
Contrast volume in mL
Deutsches Herzzentrum Muenchen
Other
A ComparIson of Strategies to Prepare Severely Calcified Coronary Lesions - A Prospective Randomized Controlled Trial of Super High-Pressure NC PTCA Balloon Versus Scoring PTCA Balloon in Severely Calcified Coronary Lesions
Acronym: ISAR-CALC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05504811
Brain Diseases, Central Nervous System Diseases
Downey, California, United States
View Trial DetailsNCT03568461
Disease Attributes, Follicular Lymphoma
Duarte, California, United States
View Trial DetailsNCT05653271
B-cell Lymphoma, Burkitt Lymphoma
Orlando, Florida, United States
View Trial DetailsNCT07673666
Astrocytoma, Astrocytoma of Brain
Mumbai, India
View Trial Details